GENE ONLINE|News &
Opinion
Blog

Policy
U.S. Government to No Longer Provide Free COVID-19 Vaccines
2022-08-31
Mounting Criticisms of FDA’s Accelerated Approval Pathway Could Prompt Changes to the System
2022-08-25
FDA Allows Sales of Over-the-Counter Hearing Aids After Five Years of Consideration
2022-08-17
EMA Responds to Monkeypox Public Health Emergency
2022-07-28
America’s Ongoing Battle For Lower Insulin Prices
2022-06-23
UK Launches World-First Program With Two Antimicrobial Drugs to Counter Superbugs
2022-06-16
China Pushes for Faster Approval for Gene-Edited Crops
2022-02-15
FDA to Support Development of Non-Opioid Painkillers
2022-02-11
Big Pharma and Non-Profits Join NIH, FDA in New Rare Diseases Drive
2021-10-28
Outlining the Future of Vaccine Business: Industry, Investment, and Public Health
2021-06-21
From Great Challenges to Great Opportunities: An Outlook on US-China Biotech Relationships
2021-06-18
M&A
Amidst Battle with FTC, Illumina Faces Scrutiny from EU Over its $7.1B GRAIL Merger
2021-04-20
Quad Members Join Forces to Produce 1 Billion Vaccines for Indo-Pacific Countries
2021-03-16
China Approves Avastin’s New Indication
2020-09-25
Part I Highlights of BIO Asia-Taiwan 2020 (Day 1): The Effect of COVID-19 on Global Biotech Industry
2020-07-22Partner
1 2
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!